middl
east
respiratori
syndrom
coronaviru
first
identifi
sinc
remain
uncontrol
case
mostli
report
middl
east
howev
travelassoci
case
outbreak
also
occur
nosocomi
zoonot
transmiss
viru
appear
import
rout
infect
sever
highli
fatal
thu
necessit
rapid
efficaci
intervent
perform
comprehens
review
publish
literatur
summar
epidemiolog
viru
addit
summar
virolog
aspect
infect
review
anim
model
use
well
vaccin
antivir
test
coronavirus
cov
becam
known
caus
human
diseas
twentieth
centuri
discov
shown
caus
respiratori
infect
human
emerg
sarscov
two
human
coronavirus
discov
hcov
hcov
new
type
coronaviru
detect
caus
sever
respiratori
ill
human
first
case
male
saudi
arabia
admit
hospit
acut
respiratori
ill
lead
pneumonia
acut
renal
failur
viru
initi
name
human
corona
virusemc
current
known
middl
east
respiratori
syndrom
coronaviru
merscov
classif
nomenclatur
merscov
phylogenet
merscov
lineag
c
coronaviru
close
relat
bat
coronavirus
root
phylogenet
analysi
show
merscov
amino
acid
sequenc
ident
less
known
cov
viru
initi
name
mani
differ
work
group
novel
coronaviru
human
coronaviru
emc
human
b
coronaviru
emc
human
b
coronaviru
englandqatar
human
b
coronaviru
b
coronaviru
england
repres
place
first
complet
viral
genom
sequenc
erasmu
medic
center
rotterdam
netherland
first
laboratoryconfirm
case
identifi
manag
jordan
qatar
england
later
name
merscov
coronavirus
studi
group
ictv
merscov
envelop
viru
posit
sens
rna
genom
coronaviru
genom
rang
kb
size
complet
sequenc
result
nucleotid
sequenc
coronaviru
genom
polycistron
larg
replicas
open
read
frame
subsequ
cleav
nonstructur
protein
nsp
region
downstream
encod
smaller
gene
includ
spike
envelop
e
membran
nucleocapsid
n
structur
protein
function
receptor
merscov
dipeptidyl
peptidas
present
human
noncili
bronchial
epitheli
cell
surfac
protein
display
high
amino
acid
sequenc
conserv
across
differ
speci
includ
sequenc
obtain
bat
cell
cell
line
suscept
studi
show
merscov
infect
sever
human
cell
line
includ
histiocyt
well
respiratori
kidney
intestin
liver
cell
rang
tissu
tropism
vitro
broader
known
human
coronaviru
merscov
also
infect
nonhuman
primat
porcin
bat
civet
rabbit
hors
cell
line
possess
receptor
replic
cycl
merscov
consist
numer
step
illustr
lu
et
al
merscov
protein
class
fusion
protein
compos
two
subunit
amino
ntermin
receptor
bind
carboxyl
ctermin
membran
fusion
subunit
junction
proteas
cleavag
site
respons
membran
fusion
activ
viru
entri
syncytium
format
c
domain
contain
receptor
bind
domain
rbd
n
domain
neutral
monoclon
antibodi
rbd
may
inhibit
viru
entri
cell
receptordepend
syncytium
format
cell
cultur
henc
vaccin
contain
rbd
induc
high
level
neutral
antibodi
mice
rabbit
cell
key
function
receptor
merscov
protein
merscov
first
cov
identifi
use
receptor
import
role
glucos
metabol
cell
activ
chemotaxi
modul
cell
adhes
apoptosi
subunit
contain
five
domain
fusion
peptid
heptad
repeat
domain
transmembran
domain
cytoplasm
domain
form
stalk
region
protein
facilit
fusion
viral
cell
membran
bind
subunit
cellular
receptor
trigger
conform
chang
subunit
insert
fusion
peptid
target
cell
membran
form
sixhelix
bundl
fusion
core
domain
approxim
viral
cell
membran
fusion
merscov
util
mani
pathway
membran
fusion
depend
avail
host
proteas
transmembran
proteas
serin
proteas
trypsin
chymotrypsin
elastas
thermolysin
endoproteinas
lysc
human
airway
trypsinlik
proteas
proteas
cleav
protein
subunit
activ
merscov
protein
endosomeindepend
host
cell
entri
plasma
membran
addit
perviou
fusion
proteas
furin
identifi
recent
play
essenti
role
merscov
protein
cleavag
activ
biolog
activ
form
cell
entri
virion
particl
disassembl
releas
nucleocapsid
viral
rna
cytoplasm
express
viral
polyprotein
doublemembran
vesicl
convolut
membran
form
attach
hydrophob
domain
merscov
replic
machineri
limit
membran
autophagosom
viral
polyprotein
cleav
papainlik
proteas
proteas
nonstructur
protein
form
replicationtranscript
complex
regul
transcript
viral
protein
express
product
abund
viral
rna
structur
accessori
protein
n
protein
bind
genom
rna
cytoplasm
form
helic
nucleocapsid
viral
core
viral
core
envelop
bud
intracellular
membran
endoplasm
reticulum
golgi
apparatu
e
protein
transport
bud
virion
nucleocapsid
probabl
interact
protein
gener
basic
structur
complex
e
protein
induc
viral
bud
releas
golgi
apparatu
merscov
replic
cycl
complet
releas
progeni
virion
cell
membran
via
exocytosi
pathway
mice
merscov
strain
inocul
three
differ
mous
strain
immunocompet
balbc
mice
innat
immunedefici
mice
intranas
signific
weight
loss
observ
infecti
viru
could
detect
lung
moder
patholog
lesion
observ
lung
henc
viral
replic
observ
strain
mice
zhao
et
al
develop
mous
model
transduc
recombin
adenoviru
vector
express
lung
tissu
inocul
merscov
mice
result
merscov
replic
without
mortal
young
mice
clear
merscov
day
old
mice
day
perivascular
peribronchi
lymphoid
infiltr
observ
progress
interstiti
pneumonia
postinfect
anoth
studi
transgen
mice
express
suscept
merscov
infect
infecti
viru
isol
lung
brain
tissu
weight
loss
observ
pascal
et
al
develop
human
transgen
mous
mortal
clinic
sign
observ
interstiti
pneumonia
signific
lung
diseas
observ
histopatholog
suggest
human
mous
model
merscov
infect
patholog
chang
resembl
merscov
infect
human
rhesu
macaqu
first
anim
model
use
merscov
infect
possess
receptor
infect
anim
increas
respiratori
rate
bodi
temperatur
cough
reduc
appetit
observ
mild
moder
sever
infecti
viru
isol
lower
respiratori
tract
viral
rna
detect
conjunctiva
nasal
mucosa
tonsil
pharynx
trachea
bronchu
lung
mild
mark
interstiti
pneumonia
dark
red
lesion
appear
lung
seroconvers
neutral
antibodi
began
dpi
increas
titer
time
develop
transient
pneumonia
rapid
replic
tropism
merscov
lower
respiratori
tract
resembl
sever
diseas
observ
human
similarli
common
marmoset
shown
possess
receptor
radiograph
imag
show
mild
sever
bilater
interstiti
infiltr
extens
bronchointertiti
pneumonia
infect
anim
infecti
viru
detect
lower
upper
respiratori
tract
tissu
viral
rna
detect
nasal
mucosa
oropharyng
swab
blood
conjunctiva
lymph
node
gastrointestin
tract
kidney
heart
adren
gland
liver
spleen
brain
lung
inocul
syrian
hamster
ferret
merscov
result
infect
rabbit
may
use
model
studi
pathogenesi
transmiss
diseas
control
strategi
merscov
vivo
seroconvert
shed
viru
inocul
septemb
novel
coronaviru
infect
note
prome
mail
viru
isol
sputum
saudi
male
admit
hospit
pneumonia
acut
kidney
injuri
june
day
later
anoth
report
appear
describ
almost
ident
viru
detect
patient
qatar
acut
respiratori
syndrom
acut
kidney
injuri
patient
recent
travel
histori
saudi
arabia
travel
uk
medic
care
two
case
jordan
april
retrospect
diagnos
mer
patient
sinc
time
case
merscov
infect
report
includ
death
actual
number
case
could
higher
report
outbreak
confirm
case
includ
death
occur
south
korea
may
june
median
age
korean
case
year
rang
year
men
health
care
profession
index
case
male
recent
travel
sever
countri
arabian
peninsula
diseas
control
prevent
cdc
ministri
health
saudi
arabia
mohsa
asymptomat
mild
sever
symptomat
mortal
case
may
classifi
suspect
probabl
confirm
person
laboratori
confirm
infect
merscov
irrespect
clinic
sign
symptom
consid
confirm
case
criteria
laboratori
confirm
requir
detect
viral
rna
acut
convalesc
serolog
presenc
nucleic
acid
confirm
posit
result
least
two
sequencespecif
rrtpcr
singl
sequencespecif
rrtpcr
test
direct
sequenc
separ
genom
target
case
confirm
serolog
method
requir
demonstr
seroconvers
two
sampl
collect
least
day
apart
use
least
one
screen
assay
enzymelink
immunoassay
immunofluoresc
assay
neutral
assay
probabl
case
defin
follow
criteria
febril
acut
respiratori
ill
pneumonia
acut
respiratori
distress
syndrom
direct
contact
confirm
merscov
case
unavail
merscov
test
result
inconclus
singl
inadequ
specimen
person
develop
fever
pneumonia
acut
respiratori
distress
syndrom
histori
travel
countri
near
arabian
peninsula
within
day
symptom
onset
contact
travel
region
develop
febril
respiratori
ill
consid
merscov
suspect
case
cdc
mohsa
recommend
laboratori
diagnost
merscov
infect
merscov
case
must
confirm
least
two
posit
qrtpcr
test
two
differ
specif
genom
region
singl
posit
qrtpcr
sequenc
anoth
posit
genom
fragment
algorithm
test
merscov
reli
qrtpcr
sequenc
avail
realtim
test
includ
assay
target
rna
upstream
e
gene
upe
highli
sensit
screen
assay
three
confirmatori
assay
target
open
read
frame
orf
n
gene
orf
assay
equal
sensit
upe
assay
orf
assay
less
sensit
use
confirm
assay
specif
merscov
shown
crossreact
respiratori
human
coronavirus
sequenc
two
target
gene
rnadepend
rna
polymeras
rdrp
present
orf
n
gene
enough
confirm
exist
merscov
rna
sampl
patient
sever
serolog
assay
includ
immunofluoresc
assay
protein
microarray
assay
enzymelink
immunosorb
assay
elisa
develop
detect
merscov
antibodi
posit
test
one
assay
confirm
neutral
assay
singl
serolog
result
may
valuabl
definit
probabl
case
follow
test
confirm
merscov
infect
incub
period
merscov
infect
studi
assiri
et
al
median
incub
period
day
ci
day
anoth
report
franc
secondari
case
patient
share
room
infect
patient
incub
period
estim
day
recent
outbreak
south
korea
mayjun
median
incub
period
day
cdc
recommend
individu
return
arabian
peninsula
affect
countri
must
evalu
merscov
infect
least
day
clinic
featur
merscov
infect
rang
asymptomat
case
mildli
ill
sever
pneumonia
acut
respiratori
distress
syndrom
septic
shock
mortal
multiorgan
failur
tabl
mani
clinic
featur
gastrointestin
symptom
anorexia
nausea
vomit
abdomin
pain
diarrhea
pericard
dissemin
intravascular
coagul
report
specif
clinic
condit
comorbid
appar
proportion
high
sever
merscov
infect
studi
assiri
et
al
saudi
arabia
show
total
patient
merscov
infect
underli
clinic
condit
includ
diabet
mellitu
hypertens
chronic
cardiac
diseas
chronic
kidney
diseas
high
rate
comorbid
must
interpret
caution
sinc
diabet
mellitu
common
saudi
arabia
approxim
half
part
outbreak
hemodialysi
unit
rate
comorbid
might
high
due
chronic
kidney
diseas
anoth
studi
dialysi
diabet
mellitu
age
year
associ
mortal
studi
test
posit
merscov
plasma
sampl
predictor
sever
outcom
younger
adult
children
appear
less
suscept
merscov
infect
one
studi
describ
merscov
infect
children
children
discov
contact
investig
older
patient
children
develop
symptom
merscov
infect
two
children
underli
condit
cystic
fibrosi
syndrom
children
asymptomat
report
merscov
infect
pregnant
women
fivemonth
pregnant
femal
develop
vagin
bleed
abdomin
pain
one
week
deliv
stillborn
infant
anoth
case
unit
arab
emir
near
term
phase
gave
birth
appar
healthi
babi
die
deliveri
mild
asymptomat
merscov
infect
report
major
identifi
among
contact
patient
report
mohsa
contact
patient
screen
use
qrtpcr
seven
healthcar
worker
merscov
infect
identifi
two
asymptomat
five
mild
upper
respiratori
tract
symptom
epidemiolog
virolog
studi
conduct
attempt
determin
person
person
transmiss
merscov
studi
case
cluster
household
hospit
outbreak
uk
tunisia
itali
healthcar
facil
saudi
arabia
franc
iran
late
south
korea
studi
provid
strong
evid
humantohuman
transmiss
occur
number
contact
infect
individu
confirm
infect
howev
appear
limit
except
outbreak
south
korea
may
june
case
secondari
case
tertiari
infect
secondari
case
often
milder
symptomless
possibl
mode
transmiss
includ
droplet
close
contact
transmiss
air
born
transmiss
fomit
transmiss
major
laboratoryconfirm
secondari
case
associ
healthcar
set
major
case
jeddah
saudi
arabia
hospit
outbreak
spring
acquir
humantohuman
transmiss
due
systemat
weak
infect
control
secondari
transmiss
rate
assess
within
household
transmiss
rate
around
suggest
actual
number
infect
greater
report
outbreak
south
korea
mayjun
secondari
infect
associ
index
case
hospit
may
may
tertiari
median
incub
period
six
day
secondari
case
six
day
tertiari
case
outbreak
also
clearli
demonstr
role
superspread
may
respons
high
proport
case
instanc
singl
patient
infect
peopl
treat
emerg
room
hospit
south
korea
three
day
may
transmiss
epidem
potenti
studi
merscov
reveal
reproduct
number
r
patient
infect
merscov
rang
find
r
suggest
merscov
yet
pandem
potenti
studi
suggest
r
valu
might
reach
absenc
infect
control
shed
period
merscov
human
report
long
virus
detect
lower
respiratori
sampl
symptomat
patient
two
week
instanc
prolong
shed
week
detect
asymptomat
healthcar
worker
find
rais
concern
asymptomat
person
could
transmit
infect
other
silent
manner
major
case
occur
saudi
arabia
unit
arab
emir
mani
case
also
report
outsid
arabian
peninsula
north
africa
europ
asia
north
america
shown
tabl
almost
case
report
outsid
arabian
peninsula
travel
histori
first
cluster
octobernovemb
four
men
famili
riyadh
saudi
arabia
two
die
second
cluster
report
jordan
april
involv
healthcar
worker
expos
fatal
patient
addit
seven
surviv
hospit
contact
seroconvert
suggest
merscov
infect
third
cluster
report
uk
januari
februari
english
resid
travel
histori
saudi
arabia
pakistan
januari
develop
sever
respiratori
ill
test
posit
merscov
influenza
die
march
infect
sever
contact
cluster
case
merscov
report
alhasa
saudi
arabia
april
case
directli
link
human
human
contact
hospit
two
confirm
case
healthcar
worker
three
famili
member
detect
survey
household
contact
visit
hospit
franc
may
infect
merscov
report
patient
recent
travel
unit
arab
emir
second
case
share
hospit
room
first
case
test
posit
first
patient
die
second
patient
critic
ill
survey
healthcar
worker
found
infect
merscov
despit
lack
use
person
protect
equip
surg
merscov
case
report
saudi
arabia
unit
arab
emir
march
april
major
case
associ
hospitalbas
outbreak
jeddah
riyadh
tabuk
madinah
saudi
arabia
well
al
abu
dhabi
unit
arab
emir
case
includ
sever
healthcar
worker
visitor
patient
ambul
staff
person
person
transmiss
confirm
case
major
infect
health
care
worker
develop
mild
symptomat
asymptomat
infect
sever
ill
die
recent
outbreak
south
korea
occur
may
index
case
man
recent
travel
bahrain
unit
arab
emir
saudi
arabia
qatar
late
juli
secondari
case
report
includ
death
mani
case
report
among
household
hospit
contact
china
one
case
occur
man
travel
china
korea
follow
exposur
two
rel
merscov
infect
spite
report
merscov
infect
throughout
year
evid
diseas
season
occur
first
identifi
case
merscov
infect
report
april
june
high
increas
case
report
april
may
follow
surg
case
report
april
may
increas
case
report
march
may
attribut
infect
infect
young
camel
sourc
mode
transmiss
merscov
still
unclear
initi
bat
origin
merscov
suggest
base
relat
genom
sequenc
merscov
bat
coronavirus
cell
tropism
studi
show
bat
coronaviru
merscov
share
cell
type
receptor
merscov
grow
readili
sever
batderiv
cell
line
evid
direct
indirect
transmiss
merscov
bat
human
virolog
studi
perform
europ
africa
asia
includ
middl
east
shown
coronaviru
rna
sequenc
found
frequent
bat
fece
sequenc
close
relat
merscov
sequenc
survey
saudi
arabia
fecal
rectal
sampl
test
pcr
merscov
mani
coronavirus
sequenc
detect
detect
sequenc
unrel
merscov
one
sequenc
nucleotid
rnadepend
rna
polymeras
rdrp
gene
ident
merscov
sequenc
detect
fece
taphoz
perforatu
bat
captur
near
home
index
saudi
patient
uncommon
contact
human
bat
indic
bat
intermedi
host
merscov
transmiss
may
reservoir
viru
dromedari
camel
camelu
dromedaru
appear
sourc
merscov
anim
like
sheep
goat
cow
test
neg
antimerscov
antibodi
camel
sera
oman
canari
island
egypt
posit
antimerscov
antibodi
sampl
respect
retrospect
studi
archiv
human
sera
show
evid
infect
merscov
antimerscov
antibodi
detect
archiv
camel
sera
saudi
arabia
unit
arab
emir
indic
circul
merscov
camel
mani
year
bactrian
camel
mongolia
test
neg
merscov
antibodi
serolog
studi
around
middl
east
suggest
camel
one
sourc
merscov
adult
camel
test
posit
high
titer
antibodi
seroposit
differ
juvenil
camel
usual
lower
adult
result
suggest
merscov
infect
camel
occur
young
age
follow
frequent
boost
camel
part
world
far
middl
east
like
europ
australia
america
merscov
antibodi
evid
infect
tabl
summar
camel
serolog
studi
studi
aim
evalu
viru
infect
shed
camel
three
adult
dromedari
camel
inocul
merscov
intratrach
intranas
conjunctiv
camel
shed
larg
quantiti
viru
upper
respiratori
tract
infecti
viru
detect
nasal
secret
day
postinocul
viral
rna
day
postinocul
human
infect
merscov
link
camel
first
evid
studi
saudi
arabia
merscov
full
genom
sequenc
isol
man
fatal
infect
one
camel
ident
patient
direct
contact
deceas
camel
day
onset
symptom
result
suggest
merscov
infect
dromedari
camel
transmit
human
direct
close
contact
studi
phylogenet
analys
camel
human
isol
merscov
genom
demonstr
virus
highli
ident
case
similar
seroepidemiolog
studi
shown
low
preval
merscov
antibodi
human
saudi
arabia
survey
individu
repres
gener
popul
saudi
arabia
result
seroposit
subject
howev
seroposit
increas
fold
camelexpos
individu
separ
report
camel
shepherd
slaughterhous
worker
test
posit
merscov
antibodi
overview
merscov
transmiss
rout
illustr
develop
effect
vaccin
critic
prevent
merscov
pandem
investig
indic
rbd
protein
merscov
protein
good
candid
antigen
subunit
vaccin
variou
rbd
fragment
show
highest
bind
affin
induc
highesttit
igg
ab
neutral
ab
mice
rabbit
robust
neutral
antibodi
respons
elicit
balbc
mice
merscov
immun
purifi
full
protein
nanoparticl
produc
cell
infect
specif
recombin
baculoviru
contain
gene
recombin
human
adenovir
vector
contain
gene
vaccinia
ankara
encod
full
protein
inocul
balbc
mice
develop
high
level
neutral
antibodi
induct
humor
cellmedi
immun
anoth
studi
use
balbc
mice
immun
venezuelan
equin
enceph
viru
replicon
particl
contain
protein
elucid
reduct
viral
titer
nearli
undetect
level
increas
neutral
antibodi
recent
wang
et
al
develop
two
candid
vaccin
subunit
full
protein
fraction
dna
vaccin
full
gene
mammalian
vector
vaccin
contain
full
dna
protein
efficaci
mice
rhesu
macaqu
use
antibodi
deter
merscov
infect
appear
promis
transfer
sera
contain
antimerscov
protein
seroposit
camel
sera
mice
acceler
viru
clearanc
inhibit
viru
attach
reduc
weight
loss
recent
corti
et
al
success
isol
monoclon
antibodi
serum
obtain
merscov
survivor
day
infect
transduc
balbc
mice
immun
mgkg
mab
show
decreas
lung
viral
titer
weight
loss
decreas
peribronchi
lymphoid
infiltr
approv
antivir
use
merscov
infect
yet
avail
first
approach
perform
new
unknown
viru
like
merscov
emerg
test
drug
use
antivir
similar
virus
type
interferon
ribavirin
combin
exhibit
accept
result
cell
cultur
rhesu
macaqu
decreas
host
inflammatori
respons
replic
viru
improv
clinic
outcom
human
cohort
studi
saudi
arabia
show
treatment
combin
ribavirin
improv
clinic
outcom
may
due
late
treatment
due
immunocompromis
state
patient
retrospect
studi
merscov
infect
patient
treat
ribavirin
interferon
result
show
surviv
improv
treat
group
compar
untreat
group
second
approach
screen
approv
drug
known
safeti
profil
transcript
signatur
differ
cell
line
sever
drug
includ
antiparasit
neurotransmitt
antibacteri
inhibitor
clathrinmedi
endocytosi
estrogen
receptor
lipid
sterol
metabol
protein
process
dna
synthesi
repair
test
cultur
cell
lopinavirritonavir
combin
pegyl
interferon
ribavirin
therapi
show
improv
outcom
infect
marmoset
third
approach
involv
vitro
inhibit
protein
block
viru
entri
host
cell
use
design
antivir
peptid
target
domain
subunit
merscov
prevent
interact
domain
requir
format
heterolog
sixhelix
bundl
viral
fusion
core
format
drug
act
inhibitor
viral
proteas
helicas
suppress
merscov
infect
test
investig
studi
inhibit
merscov
infect
competit
inhibit
cell
receptor
use
compound
sitagliptin
vildagliptin
saxagliptin
three
year
pass
sinc
first
detect
merscov
human
infect
viru
uncontrol
continu
caus
major
outbreak
middl
east
recent
outbreak
korea
demonstr
singl
index
case
lead
infect
short
period
time
henc
rais
question
accuraci
number
case
report
middl
east
furthermor
korean
outbreak
confirm
high
fatal
rate
merscov
infect
true
rather
overestim
case
sever
case
detect
public
health
veterinari
health
research
effort
need
consolid
order
answer
follow
high
prioriti
question
true
extent
human
infect
merscov
antivir
vaccin
use
human
infect
control
measur
need
healthcar
set
prevent
nosocomi
outbreak
measur
need
place
order
prevent
zoonot
infect
camel
possibl
control
viru
camel
popul
anim
speci
involv
merscov
transmiss
cycl
